Dedicated to advancing research that improves the understanding & development of therapeutics for MEF2C Haploinsufficiency Syndrome (MCHS)
Employees
1-10Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
